Phibro Animal Health Corporation (PAHC)
Automate Your Wheel Strategy on PAHC
With Tiblio's Option Bot, you can configure your own wheel strategy including PAHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PAHC
- Rev/Share 29.3996
- Book/Share 6.5677
- PB 3.7243
- Debt/Equity 2.8949
- CurrentRatio 2.9121
- ROIC 0.0522
- MktCap 991452052.0
- FreeCF/Share 1.2113
- PFCF 20.2098
- PE 31.1597
- Debt/Assets 0.5846
- DivYield 0.0245
- ROE 0.1237
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | PAHC | JP Morgan | -- | Neutral | -- | $22 | Sept. 10, 2024 |
News
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Is PAHC Stock a Smart Addition to Your Portfolio Right Now?
Published: February 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro's robust performance in the Animal Health business and prospects in the emerging markets are highly encouraging.
Read More
3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC)
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
Read More
PAHC or SYK: Which Is the Better Value Stock Right Now?
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Bears are Losing Control Over Phibro (PAHC), Here's Why It's a 'Buy' Now
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Negative
Phibro (PAHC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Read More
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Phibro Animal Health Corporation to Participate at Bank of America 2025 Virtual Animal Health Summit
Published: February 20, 2025 by: Business Wire
Sentiment: Neutral
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2025 Virtual Animal Health Summit. Chief Financial Officer, Glenn David will address financial analysts and investors on Thursday, February 27, 2025, at 10:50 AM ET. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com. A replay of the session will be available and arch.
Read More
4 PEG-Based Value Stocks to Shield Your Portfolio From Trade War
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Here are four PEG-driven GARP stocks, GM, EXPE, PAHC and PPC, which qualify our screening criteria.
Read More
Best Momentum Stocks to Buy for February 14th
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
FINW, SFTBY and PAHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 14, 2025.
Read More
4 Stocks Trading Near 52-Week High With More Upside Potential
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Stocks like NFG, ENS, PAHC and C are seeing price strength and have a high chance of carrying the momentum forward.
Read More
New Strong Buy Stocks for February 14th
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
FRSH, SFTBY, ATGE, FINW and PAHC have been added to the Zacks Rank #1 (Strong Buy) List on February 14, 2025.
Read More
Best Value Stocks to Buy for February 14th
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
ATGE and PAHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 14, 2025.
Read More
Best Income Stocks to Buy for February 14th
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 14, 2025.
Read More
Phibro Animal Health (PAHC) Is Up 8.62% in One Week: What You Should Know
Published: February 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: February 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
About Phibro Animal Health Corporation (PAHC)
- IPO Date 2014-04-11
- Website https://www.pahc.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Mr. Jack Clifford Bendheim
- Employees 1940